Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Effects Toxics”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03690427
What this trial is testing

The Cardiovascular Effects of Electronic Hookah Vaping

Who this might be right for
Endothelial DysfunctionInflammationOxidative Stress
University of California, Los Angeles 19
Not applicableStudy completedNCT06778122
What this trial is testing

In-Bedroom Renewed Air as Anti-inflammatory Adjuvant Therapy in Cancer Survivors

Who this might be right for
Cancer SurvivorsCardiotoxicityCardiovascular Toxicity Induced by Antitumoral Drugs
University College, London 10
Not applicableStudy completedNCT04799080
What this trial is testing

Chemotherapy-induced Peripheral Neuropathy (CIPN) on Motor and Sensory Function

Who this might be right for
CancerChemotherapy-induced Peripheral NeuropathyChemotherapeutic Toxicity+4 more
Izmir Bakircay University 72
Not applicableUnknownNCT03839069
What this trial is testing

Minor Salivary Gland Transplantation for Cicatrizing Conjunctivitis

Who this might be right for
Cicatrizing ConjunctivitisStevens-Johnson Syndrome Toxic Epidermal Necrolysis SpectrumSjogren Syndrome+3 more
National Taiwan University Hospital 30
Early research (Phase 1)Study completedNCT03930680
What this trial is testing

Prevention of Heart Failure Induced by Doxorubicin With Early Administration of Dexrazoxane

Who this might be right for
Degradation of Top2b and Top2a in Human by DexrazoxaneTime Course and Degradation of Top2b in Human by DexrazoxaneEffects of Dexrazoxane on Healthy Human
University of Arkansas 25
Early research (Phase 1)Study completedNCT01979380
What this trial is testing

Phase I Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics of KD101 in Healthy Male Subjects

Who this might be right for
Drug Toxicity
Kwang Dong Pharmaceutical co., ltd. 40
Testing effectiveness (Phase 2)Study completedNCT05277480
What this trial is testing

Apatinib With Ifosfamide Plus Etoposide for Relapsed or Refractory Osteosarcoma (OAIE)

Who this might be right for
Effect of DrugDrugToxicity
Peking University People's Hospital 81
Testing effectiveness (Phase 2)Study completedNCT00028964
What this trial is testing

Combination Chemotherapy After Surgery With or Without Chinese Herbal Therapy to Treat Symptoms in Women With Breast Cancer

Who this might be right for
Breast CancerDrug/Agent Toxicity by Tissue/Organ
University of California, San Francisco
Not applicableUnknownNCT04867564
What this trial is testing

Radiation-induced Cardiac Toxicity After Non-small Cell Lung Cancer Radiotherapy

Who this might be right for
Non-small Cell Lung CancerRadiation ToxicityCardiac Toxicity
Military Institute od Medicine National Research Institute 100
Not applicableStudy completedNCT03882541
What this trial is testing

Could Music be an Alternative to Sedation in Patients Treated Total Knee Arthroplasty With Regional Anesthesia?

Who this might be right for
AnxietySurgeryDrug Toxicity+2 more
Consorci Sanitari de l'Anoia 85
Very early researchLooking for participantsNCT06119490
What this trial is testing

Evaluation of the Efficacy and Safety of Methylprednisolone Combined With the JAK Inhibitors in the Treatment of Toxic Epidermal Necrolysis

Who this might be right for
Toxic Epidermal Necrolysis
Peng Zhang 30
Testing effectiveness (Phase 2)Study completedNCT01009918
What this trial is testing

Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab

Who this might be right for
Breast CancerCardiac Toxicity
University of South Florida 468
Not applicableUnknownNCT03746340
What this trial is testing

The Effects of Different General Anesthetics on Serum Folic Acid and Homocysteine Concentrations in Children

Who this might be right for
Anesthetic Toxicity
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 40
Early research (Phase 1)Study completedNCT00016679
What this trial is testing

1-Octanol to Treat Essential Tremor

Who this might be right for
Essential Tremor
National Institute of Neurological Disorders and Stroke (NINDS) 42
Not applicableStudy completedNCT00875238
What this trial is testing

Side Effects Involving the Heart in Women With Breast Cancer Receiving Doxorubicin and Trastuzumab

Who this might be right for
Breast CancerCardiac ToxicityCardiovascular Complications
Vanderbilt University 133
Large-scale testing (Phase 3)Study completedNCT04059809
What this trial is testing

Photobiomodulation for Breast Cancer Radiodermatitis

Who this might be right for
Breast CancerRadiodermatitisRadiotherapy Side Effect+5 more
AC Camargo Cancer Center 48
Not applicableStudy completedNCT00681993
What this trial is testing

Trial of Partial Breast Irradiation With Various Concurrent Chemotherapy Regimens

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35
Testing effectiveness (Phase 2)UnknownNCT01627938
What this trial is testing

Study to Evaluate the Reduction of Cardiac Problems in Multiple Sclerosis Patients With Mitoxantrone and Dexrazoxane in Combination

Who this might be right for
Multiple Sclerosis
PD Dr. Andrew Chan 50
Large-scale testing (Phase 3)Ended earlyNCT00016276
What this trial is testing

Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer

Who this might be right for
Cardiac ToxicityInflammatory Breast CancerStage IIIA Breast Cancer+2 more
National Cancer Institute (NCI) 396
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07110662
What this trial is testing

New Therapeutic Target for Toxic Epidermal Necrolysis (TEN) Using Anti-CD38+ Monoclonal Antibodies.

Who this might be right for
Toxic Epidermal NecrolysisImmunotherapyCutaneous Adverse Drug Reactions (CADR)
Hospices Civils de Lyon 9
Next Page